miércoles, 26 de agosto de 2015

Taking stock of new Alzheimer's drug coverage: A "landmark breakthrough" that offers no "clinically apparent benefit" - HealthNewsReview.org

Taking stock of new Alzheimer's drug coverage: A "landmark breakthrough" that offers no "clinically apparent benefit" - HealthNewsReview.org

alzheimers

Taking stock of new Alzheimer’s drug coverage: A “landmark breakthrough” that offers no “clinically apparent benefit”

POSTED BY

CATEGORIES

Drug industry, News from scientific meetings

TAGS

, ,
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)